ResearcherJuntendo UniversityNo recent work listed

Ko Tomishima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6206-9236. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper

Papers 1

Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers13164224 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Toshio Fujisawa · 1 shared paper, 2021 · strength 0.11
- Paper Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Adv… DOI 10.3390/cancers13164224 ↗
Hiroyuki Isayama · 1 shared paper, 2021 · strength 0.11
- Paper Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Adv… DOI 10.3390/cancers13164224 ↗
Yusuke Takasaki · 1 shared paper, 2021 · strength 0.11
- Paper Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Adv… DOI 10.3390/cancers13164224 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.